← Explorer/Network

Scanning cytophotometric analysis of brain neuronal nuclear chromatin changes in acute T-2 toxin-treated rats

L J Martin, J A Doebler, A Anthony1986Toxicology and Applied PharmacologyJournal Article
Hypothalamic-PituitaryImmune/InnateNeurologicalOcularRespiratory/Sinus

Abstract

Male Sprague-Dawley rats (200 g) were injected intraperitoneally with T-2 toxin, a trichothecene mycotoxin protein synthesis inhibitor, at dosages of 0.75, 1.0, 1.5, and 6.0 mg/kg (1 LD50 = 0.9 mg/kg) before decapitation at 8-hr postexposure. Correlative data were obtained on changes in physicochemical properties of nuclear chromatin, chromatin dispersion, and nuclear volume of cerebrocortical (layer III) and striatal neurons using Feulgen-DNA (F-DNA) cytophotometry and ocular filar micrometry. Decreased lability of neurons to F-DNA acid hydrolysis (reduced F-DNA yield), nuclear shrinkage, and chromatin aggregation (decreased chromophore area) were used as indices of suppression of genomic template activity, i.e., neuronal nuclear functioning. Conversely, increased F-DNA yield, chromophore area, and nuclear volume signify enhanced neuronal activation. At 8 hr following T-2 toxin exposure, cerebrocortical and striatal neurons exhibited a dose-dependent decrease in F-DNA hydrolyzability, i.e., impaired chromatin activity, and increases in both chromatin dispersion and nuclear volume. Microscopic observation revealed no gross evidence of T-2 induced neurotoxicity. These data indicate that T-2 toxin elicits both neurochemical injury and adaptive or compensatory processes simultaneously. The toxicological importance of observed nuclear alterations and the role of impairments in central nervous system metabolism in acute T-2 toxicity remain to be ascertained.

Part of Mold & water-damaged buildings research, Mycotoxins research · Curated by Lauren Lowenstein, The Biotoxin Lady

Key Biomarkers

Abnormal nerve conduction studiesAbnormal QEEG with frontal hypoactivationAbnormal T and B cell subsetsAnti-smooth muscle autoantibodies (ASM)Antinuclear autoantibodies (ANA)CNS and PNS myelin autoantibodiesElevated neural autoantibodies (anti-myelin basic protein, anti-ganglioside GM1, anti-sulfatide)Trichothecene toxin in urine and serum

Symptom Clusters

Autonomic nervous system dysfunctionBalance and coordination abnormalitiesCognitive impairment consistent with mild traumatic brain injuryMood disorders and psychological symptomsNeurobehavioral impairment (memory loss, concentration deficits, executive dysfunction)Peripheral neuropathy (numbness, tingling, tremors, muscle weakness)Respiratory symptoms (rhinorrhea, wheezing, airway obstruction)Visuospatial and verbal learning deficits